Dublin, May 14, 2018 (GLOBE NEWSWIRE) — The “The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology)” report has been added to ResearchAndMarkets.com’s offering.
Clinical microbiology laboratories perform tests to detect, isolate, identify and characterize microorganisms that cause infectious diseases, and also perform antibiotic susceptibility tests. This is a diverse market. Traditional microbiology, including culture, microscopy, use of stains plus fluorogenic and chromogenic substrates, and other technologies has been used for several decades in microbiology laboratories. Microbiology tests may be performed using traditional microbiology techniques, or by using newer technologies including immunoassays, molecular microbiology (PCR or other nucleic acid amplification methods), or mass spectrometry.
A wide range of technologies are used today to detect and characterize pathogens, or to detect the effect an infectious disease pathogen has on a patient’s body. Selected technologies used for infectious disease diagnostics are discussed in the report, including:
- Traditional Microbiology: Identification and antibiotic susceptibility/sensitivity testing (ID/AST), which includes the following product categories: microbial ID/AST systems, and panels and reagents for ID/AST systems; chromogenic media; rapid tests done on colonies selected from culture media; and blood culture bottles and systems
- Mass Spectrometry: The development of MALDI-TOF mass spectrometers has made it possible to apply mass spectrometry to infectious disease diagnostics applications, and mass spectrometers are now being used in microbiology laboratories for rapid identification of pathogens following cell culture
- Immunoassays: Those discussed include traditional rapid assays (flow through assays and immunolochromatographic tests) and enzyme immunoassays
- Polymerase Chain Reaction and Other Nucleic Acid Amplification Technologies: Assays based on PCR and certain other nucleic acid amplification technologies are widely used in clinical laboratories, and are penetrating near patient and point-of-care settings
The Worldwide Microbiology Market also looks at advances in molecular microbiology. Until recently, sequencing applications in microbiology have been limited. This is starting to change. At this time, next generation sequencing based tests are mostly laboratory developed tests for oncology or genetic testing. However, companies are starting to apply next generation sequencing to infectious disease diagnostics. The report outlines selected companies applying DNA/RNA sequencing to microbiology.
The report contains profiles of a wide range of companies that are active in the clinical microbiology market, which includes companies that in the traditional microbiology market, immunoassay market, molecular microbiology market, and also mass spectrometry systems for the microbiology laboratory.
Key Topics Covered:
1. Executive Summary
- Overview
- Scope and Methodology
- Market Overview
2. Introduction
- The Microbiology Laboratory
- Traditional Microbiology – Microbial Identification and Antibiotic Susceptibility Testing (ID/AST)
- Advances in Microbiology
- The Quest for Rapid Microbial Identification/Antibiotic Susceptibility (Resistance) Tests
- Point-of-View and Methodology
3. Why Care about What Is Happening in Microbiology? Infectious Disease Trends
- Burden of Infectious Disease
- Emerging Threats
- The Problem of Microbial Antibiotic Resistance
- Limitations of Traditional Microbiology
- Needed: Rapid Microbial Identification and Antibiotic Susceptibility/Resistance Tests
4. Selected Technologies/Platforms in Microbiology Laboratories
- Traditional Microbiology
- Overview of Traditional Microbial ID/AST
- ID/AST Systems, and Panels and Reagents for ID/AST Systems
- Chromogenic Media
- Rapid Tests Performed on Colonies from Culture Media
- Blood Culture
- Mass Spectrometry
- Immunoassays
- Traditional Rapid Immunoassay Technologies – Flow Through Assays and Immunochromatographic (Lateral Flow) Tests
- Enzyme Immunoassays
- Polymerase Chain Reaction and Other Nucleic Acid Amplification Technologies
5. Advances in the Microbiology Laboratory
- Liquid Microbiology and ID/AST Automation
- Advances in Microbial Identification Following Blood Culture
- Mass Spectrometry
- PCR and Other NAAT Based Tests for Infectious Diseases
- Next Generation Sequencing
6. Applications and Advances in Molecular Microbiology
- Applications of Molecular Testing in the Microbiology Laboratory – Selected Examples
- Sexually Transmitted Diseases and Women’s Health
- Hepatitis
- HIV
- Hospital-Acquired Infections (HAIs)
- Respiratory Infections
- Tuberculosis
- Multiplex Tests and Syndromic Testing
- What is Syndromic Testing and Why is ii Important?
- When Should Syndromic Testing Be Performed? Syndromic Testing versus Traditional Single or Duplex Multiple Diagnostic Tests
7. Rapid Microbiology
- “Rapid” Testing in Microbiology Labs Today – Faster Than Traditional Microbiology, But
- Making Progress – Development of Faster Identification and Antimicrobial Susceptibility/Resistance Tests for the Microbiology Lab and Near Patient or Point-of-Care
8. Corporate Deals in Microbiology
- Investments and Financing Agreements
- Merger and Acquisitions
- Corporate Agreements and Collaborations
- Microbiology Company Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
9. Market Drivers, Challenges, and Trends in Microbiology
- Cost of Molecular Microbiology Tests versus Traditional Microbiology
- Clinical Market Drivers
- Near-Patient and Point-of-Care Testing Market Drivers and Challenges/Hurdles
- Competition
- Regulation
- Reimbursement
- Future Prospects
10. Microbiology Market Analysis
- Worldwide Microbiology Market
- Traditional Microbiology ID/AST Market
- Microbial Identification and Antimicrobial Susceptibility Systems
- Blood Culture
- Chromogenic Media
- Rapid Tests Performed on Colonies from Culture Media
- Microbiology/Infectious Disease Immunoassay Market
- Molecular Microbiology Market
- Microbiology Mass Spectrometry Market
- Future Market Potential for Rapid Microbial Identification and Antibiotic Susceptibility/Resistance Tests
11. Company Profiles
- 3i Diagnostics, Inc. (3iDx)
- Abbott
- Accelerate Diagnostics, Inc.
- Atlas Genetics Ltd.
- AutoGenomics, Inc.
- Beckman Coulter, Inc. (A Danaher Corporation Company)
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- BioFire Diagnostics, LLC. (Acquired by bioMrieux)
- bioMrieux SA
- Bruker Corporation
- Cepheid (A Danaher Company)
- COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
- Curetis
- DiaSorin S.p.A.
- ELITech Group
- GenePOC Inc.
- GenMark Diagnostics, Inc.
- Hologic, Inc.
- Janssen Diagnostics (Janssen Pharmaceutical Companies of Johnson & Johnson)
- Luminex Corporation
- Mast Group
- Q-linea AB
- QIAGEN N.V.
- QuanDx Inc.
- QuantuMDx Group
- Quidel, Inc.
- Qvella Corporation
- Rheonix, Inc.
- Roche
- Siemens Healthineers
- THERMO FISHER SCIENTIFIC INC
- Xagenic Inc.
For more information about this report visit https://www.researchandmarkets.com/research/b2kv68/worldwide?w=12
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics
